Driehaus Capital Management
http://www.driehaus.com/index.cfmDriehaus Capital Management is an investment management firm serving institutional clients, high net worth individuals and mutual fund investors. The firm specializes in domestic and international equity investing through separately managed accounts and mutual funds. Driehaus Capital Management was formed in 1982.
View Older Stories View More Recent Stories
-
Form SC 13G APPLIED OPTOELECTRONICS, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Blue Foundry Bancorp Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Sonendo, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Crinetics Pharmaceutical Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Xenon Pharmaceuticals Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Astria Therapeutics (ATXS) Prices 10.34M Share Offering at $12.09/sh
-
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
-
Skye Bioscience (SKYE) Announces $50.25M Private Placement
-
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
-
Form SC 13G Xponential Fitness, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Real Good Food Company, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted Medicines
-
Form SC 13G/A MELI Kaszek Pioneer Corp Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs
-
Aeglea BioTherapeutics (AGLE) Acquires Spyre Therapeutics
-
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
-
Congruence Therapeutics Announces Close of Series A Extension, Bringing Total Round to Over US$65 Million
-
Form SC 13G Xponential Fitness, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G Sonendo, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G Blue Foundry Bancorp Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Xenon Pharmaceuticals Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A MELI Kaszek Pioneer Corp Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Real Good Food Company, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Crinetics Pharmaceutical Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A DICE Therapeutics, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares
-
VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares
-
Form SC 13G/A First Light Acquisition Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
VectivBio Holding AG (VECT) Prices $125 Million Underwritten Offering of Ordinary Shares at $7.50/sh
-
VectivBio Announces Pricing of $125 Million Underwritten Offering of Ordinary Shares
-
VectivBio Announces Pricing of $125 Million Underwritten Offering of Ordinary Shares
-
Form SC 13G/A First Light Acquisition Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Sonendo, Inc (SONX) Announces $63M Private Placement Priced at $0.95/sh
-
Sonendo, Inc. Announces $63 Million Private Placement
-
Ventyx Biosciences (VTYX) Announces $176.6 Million Private Placement of Common Stock
-
Ventyx Biosciences Announces $176.6 Million Private Placement of Common Stock
-
Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025
-
Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025
-
Form SC 13G/A Elevation Oncology, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Annexon (ANNX) Announces $130 Million Private Placement Financing
-
Annexon Announces $130 Million Private Placement Financing
-
Annexon Announces $130 Million Private Placement Financing
-
Form SC 13G Real Good Food Company, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G MELI Kaszek Pioneer Corp Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Elevation Oncology, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A CHANNELADVISOR CORP Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G/A CYTOKINETICS INC Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G First Light Acquisition Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G DICE Therapeutics, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
-
Form SC 13G Elevation Oncology, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC

